These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24630437)

  • 21. New drugs to treat hereditary angioedema.
    Scheinfeld N
    Skinmed; 2013; 11(6):357-9. PubMed ID: 24517042
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.
    Stolz LE; Sheffer AL
    Expert Rev Clin Immunol; 2012 Jan; 8(1):25-32. PubMed ID: 22149337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
    Nzeako UC; Longhurst HJ
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary angioedema: new hopes for an orphan disease.
    Reshef A; Leibovich I; Goren A
    Isr Med Assoc J; 2008 Dec; 10(12):850-5. PubMed ID: 19160940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of hereditary angioedema attacks requiring a second dose of ecallantide.
    Li HH; Campion M; Craig TJ; Soteres DF; Riedl M; Lumry WR; MacGinnitie AJ; Shea EP; Bernstein JA
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):168-72. PubMed ID: 23548526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery.
    Lehmann A
    Expert Opin Biol Ther; 2008 Aug; 8(8):1187-99. PubMed ID: 18613770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary angioedema--treatment].
    Muszyńska A; Fal AM
    Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When is prophylaxis for hereditary angioedema necessary?
    Craig T; Riedl M; Dykewicz MS; Gower RG; Baker J; Edelman FJ; Hurewitz D; Jacobs J; Kalfus I
    Ann Allergy Asthma Immunol; 2009 May; 102(5):366-72. PubMed ID: 19492656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.
    Sheffer AL; MacGinnitie AJ; Campion M; Stolz LE; Pullman WE
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):184-188.e2. PubMed ID: 23548529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC; Zuraw BL
    Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home i.v. therapy comes of age.
    Masoorli S
    RN; 1996 Oct; 59(10):22-5; quiz 26. PubMed ID: 8966479
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
    Krause K; Metz M; Zuberbier T; Maurer M; Magerl M
    J Dtsch Dermatol Ges; 2010 Apr; 8(4):272-4. PubMed ID: 19758369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema.
    Kreuz W; Rusicke E; Martinez-Saguer I; Aygören-Pürsün E; Heller C; Klingebiel T
    Transfusion; 2012 Jan; 52(1):100-7. PubMed ID: 21756262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I.v. push at home?
    Skokal W
    RN; 2000 Oct; 63(10):26-9; quiz 30. PubMed ID: 11062663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.
    Cicardi M; Bork K; Caballero T; Craig T; Li HH; Longhurst H; Reshef A; Zuraw B;
    Allergy; 2012 Feb; 67(2):147-57. PubMed ID: 22126399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of peripheral attacks in hereditary angioedema patients.
    Kusuma A; Relan A; Knulst AC; Moldovan D; Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Hack CE
    Am J Med; 2012 Sep; 125(9):937.e17-24. PubMed ID: 22748405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on hereditary angioedema.
    Hsu D; Shaker M
    Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New hope for those with hereditary angioedema.
    Pepe J; Bielory L
    Nursing; 2012 Apr; 42(4):43-6. PubMed ID: 22456213
    [No Abstract]   [Full Text] [Related]  

  • 39. [Risk related to implant sites in home infusion therapy].
    Laumond R
    Soins; 2001 Nov; (660):46-8. PubMed ID: 12013000
    [No Abstract]   [Full Text] [Related]  

  • 40. Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate.
    Bork K; Hardt J
    Am J Med; 2009 Aug; 122(8):780-3. PubMed ID: 19635282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.